Eloralintide dosage and reconstitution
Lilly's weekly fullness shot: up to 20 percent weight loss in a year with nausea near placebo. In trials; nothing sold is the real thing.
Staying safe
Things people sometimes notice
- Mild nausea, mainly in the week after a dose increase
- Eating noticeably less without trying, which is the effect
- Tiredness in the first weeks, the second most common complaint in the trial, and in some people with long use
- Constipation or loose stools while the gut adjusts
Stop and get help if (trouble breathing or swelling: call 911)
- Severe or constant stomach pain, especially spreading to the back, a pancreatitis warning
- Vomiting that keeps you from holding down fluids
- Hives or swelling of the face or lips
Talk to your doctor first, especially if
- You have had pancreatitis, a caution it shares with every drug in this class
- You take insulin or sulfonylureas, because eating much less can drop blood sugar too far
- You have gastroparesis, which any fullness drug can worsen, especially with a GLP-1
- You are pregnant, nursing or trying to be; the trials excluded you and there is no data
Mixing it
Works on the amylin receptor rather than the GLP-1 pathway, so it curbs appetite centrally instead of slowing your stomach. The half-life is about two weeks, which means any change you make takes roughly a month to fully show up. Step up slowly and give each dose time before judging it.
Bring the vial to room temperature and wipe the top with an alcohol swab.
Add bacteriostatic water slowly against the side of the glass, then confirm your draw with the calculator.
Swirl gently until dissolved. Do not shake.
Inject once a week and hold each dose for about 4 weeks before stepping up.
Store in the fridge per the label.